Clinical trials sponsored by University of Nottingham

Phase breakdown

Conditions studied

Recruiting trials led by University of Nottingham

• Early Psychosis: Investigating Cognition
  NCT07196423 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• Improving Patient Assessment After Acute Kidney Injury (AKI)
  NCT07569588 · Phase: Not specified · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• In-Depth Characterisation of Biliary Strictures and Hepato-Pancreato-Biliary Focal Lesions for Development of New Technologies to Tackle Hepato-Pancreato-Biliary Cancers
  NCT07206355 · Phase: Not specified · Ages: 16 Years and older · Sex: All (male and female) · 1 location
• Intra-operative Detection of Positive Margins and Lymph Nodes in Breast Surgery
  NCT06977698 · Phase: Not specified · Ages: No age limits stated · Sex: Female · 1 location
• Investigating the Role of Central Pain Hypersensitivity in Skeletal Muscle Neural Drive
  NCT07281651 · Phase: Not specified · Ages: 40 Years and older · Sex: All (male and female) · 1 location
• Lived Experience Narratives in Dementia
  NCT07757178 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 99 Years · Sex: All (male and female) · 2 locations
• NAZA - Nottingham/Astra ZenecA Prospective IBD Cohort Study
  NCT06956703 · Phase: Not specified · Ages: 16 Years and older · Sex: All (male and female) · 2 locations
• Nottingham Community Liver Biomarkers Cohort
  NCT02037867 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Postoperative Electrical Muscle Stimulation Two
  NCT06964438 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Stopping PPI Therapy in Inactive IBD
  NCT07691138 · Phase: Phase 4 · Ages: 16 Years and older · Sex: All (male and female) · 2 locations
• The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
  NCT07093346 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 3 locations

Common questions

How many trials is University of Nottingham recruiting for?

University of Nottingham is the lead sponsor of 11 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.